Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 35 entries
Sorted by: Best Match Show Resources per page
Chronic pain treatment preferences change following participation in N-of-1 trials, but not always in the expected direction.

Journal of clinical epidemiology

Kravitz RL, Marois M, Sim I, Ward D, Kanekar SS, Yu A, Dounias P, Yang J, Wang Y, Schmid CH.
PMID: 34400254
J Clin Epidemiol. 2021 Nov;139:167-176. doi: 10.1016/j.jclinepi.2021.08.007. Epub 2021 Aug 14.

OBJECTIVE: To examine pain treatment preferences before and after participation in an N-of-1 trial.STUDY DESIGN AND SETTING: In this observational study nested within a randomized trial, we examined chronic pain patients' preferences before and after treatment in relation to...

Cite
Kravitz RL, Marois M, Sim I, et al. Chronic pain treatment preferences change following participation in N-of-1 trials, but not always in the expected direction. J Clin Epidemiol. 2021;139:167-176doi: 10.1016/j.jclinepi.2021.08.007.
Kravitz, R. L., Marois, M., Sim, I., Ward, D., Kanekar, S. S., Yu, A., Dounias, P., Yang, J., Wang, Y., & Schmid, C. H. (2021). Chronic pain treatment preferences change following participation in N-of-1 trials, but not always in the expected direction. Journal of clinical epidemiology, 139167-176. https://doi.org/10.1016/j.jclinepi.2021.08.007
Kravitz, Richard L, et al. "Chronic pain treatment preferences change following participation in N-of-1 trials, but not always in the expected direction." Journal of clinical epidemiology vol. 139 (2021): 167-176. doi: https://doi.org/10.1016/j.jclinepi.2021.08.007
Kravitz RL, Marois M, Sim I, Ward D, Kanekar SS, Yu A, Dounias P, Yang J, Wang Y, Schmid CH. Chronic pain treatment preferences change following participation in N-of-1 trials, but not always in the expected direction. J Clin Epidemiol. 2021 Nov;139:167-176. doi: 10.1016/j.jclinepi.2021.08.007. Epub 2021 Aug 14. PMID: 34400254.
Copy Download .nbib Format: NLM
Megacystis in the first trimester of pregnancy: Prognostic factors and perinatal outcomes.

PloS one

Lesieur E, Barrois M, Bourdon M, Blanc J, Loeuillet L, Delteil C, Torrents J, Bretelle F, Grangé G, Tsatsaris V, Anselem O.
PMID: 34492029
PLoS One. 2021 Sep 07;16(9):e0255890. doi: 10.1371/journal.pone.0255890. eCollection 2021.

OBJECTIVE: To determine whether bladder size is associated with an unfavorable neonatal outcome, in the case of first-trimester megacystis.MATERIALS AND METHODS: This was a retrospective observational study between 2009 and 2019 in two prenatal diagnosis centers. The inclusion criterion...

Cite
Lesieur E, Barrois M, Bourdon M, et al. Megacystis in the first trimester of pregnancy: Prognostic factors and perinatal outcomes. PLoS One. 2021;16(9):e0255890doi: 10.1371/journal.pone.0255890.
Lesieur, E., Barrois, M., Bourdon, M., Blanc, J., Loeuillet, L., Delteil, C., Torrents, J., Bretelle, F., Grangé, G., Tsatsaris, V., & Anselem, O. (2021). Megacystis in the first trimester of pregnancy: Prognostic factors and perinatal outcomes. PloS one, 16(9), e0255890. https://doi.org/10.1371/journal.pone.0255890
Lesieur, Emmanuelle, et al. "Megacystis in the first trimester of pregnancy: Prognostic factors and perinatal outcomes." PloS one vol. 16,9 (2021): e0255890. doi: https://doi.org/10.1371/journal.pone.0255890
Lesieur E, Barrois M, Bourdon M, Blanc J, Loeuillet L, Delteil C, Torrents J, Bretelle F, Grangé G, Tsatsaris V, Anselem O. Megacystis in the first trimester of pregnancy: Prognostic factors and perinatal outcomes. PLoS One. 2021 Sep 07;16(9):e0255890. doi: 10.1371/journal.pone.0255890. eCollection 2021. PMID: 34492029; PMCID: PMC8423287.
Copy Download .nbib Format: NLM
[The responsibility of science].

Revue francaise d'odonto-stomatologie

Marois M.
PMID: 5251991
Rev Fr Odontostomatol. 1969 Jan;16(1):31-40.

No abstract available.

Cite
Marois M. La responsabilité de la science. [The responsibility of science]. Rev Fr Odontostomatol. 1969;16(1):31-40
Marois, M. (1969). La responsabilité de la science. [The responsibility of science]. Revue francaise d'odonto-stomatologie, 16(1), 31-40.
Marois, M. "La responsabilité de la science." [The responsibility of science]. Revue francaise d'odonto-stomatologie vol. 16,1 (1969): 31-40.
Marois M. La responsabilité de la science. [The responsibility of science]. Rev Fr Odontostomatol. 1969 Jan;16(1):31-40. French. PMID: 5251991.
Copy Download .nbib Format: NLM
Involvement of patient organisations in research and development of orphan drugs for rare diseases in europe.

Molecular syndromology

Mavris M, Le Cam Y.
PMID: 23293582
Mol Syndromol. 2012 Nov;3(5):237-43. doi: 10.1159/000342758. Epub 2012 Sep 13.

Patients' representatives have an increasingly present voice in all aspects of drug development from fundamental research through regulatory processes to health technology assessment. Although major advances have been made in raising awareness and increasing funding for rare diseases, important...

Cite
Mavris M, Le Cam Y. Involvement of patient organisations in research and development of orphan drugs for rare diseases in europe. Mol Syndromol. 2012;3(5):237-43doi: 10.1159/000342758.
Mavris, M., & Le Cam, Y. (2012). Involvement of patient organisations in research and development of orphan drugs for rare diseases in europe. Molecular syndromology, 3(5), 237-43. https://doi.org/10.1159/000342758
Mavris, M, and Le Cam, Y. "Involvement of patient organisations in research and development of orphan drugs for rare diseases in europe." Molecular syndromology vol. 3,5 (2012): 237-43. doi: https://doi.org/10.1159/000342758
Mavris M, Le Cam Y. Involvement of patient organisations in research and development of orphan drugs for rare diseases in europe. Mol Syndromol. 2012 Nov;3(5):237-43. doi: 10.1159/000342758. Epub 2012 Sep 13. PMID: 23293582; PMCID: PMC3531929.
Copy Download .nbib Format: NLM
Rotational spectroscopy of the isotopic species of silicon monosulfide, SiS.

Physical chemistry chemical physics : PCCP

Müller HS, McCarthy MC, Bizzocchi L, Gupta H, Esser S, Lichau H, Caris M, Lewen F, Hahn J, Degli Esposti C, Schlemmer S, Thaddeus P.
PMID: 17429551
Phys Chem Chem Phys. 2007 Apr 07;9(13):1579-86. doi: 10.1039/b618799d. Epub 2007 Feb 20.

Pure rotational transitions of silicon monosulfide ((28)Si(32)S) and its rare isotopic species have been observed in their ground as well as vibrationally excited states by employing Fourier transform microwave (FTMW) spectroscopy of a supersonic molecular beam at centimetre wavelengths...

Cite
Müller HS, McCarthy MC, Bizzocchi L, et al. Rotational spectroscopy of the isotopic species of silicon monosulfide, SiS. Phys Chem Chem Phys. 2007;9(13):1579-86doi: 10.1039/b618799d.
Müller, H. S., McCarthy, M. C., Bizzocchi, L., Gupta, H., Esser, S., Lichau, H., Caris, M., Lewen, F., Hahn, J., Degli Esposti, C., Schlemmer, S., & Thaddeus, P. (2007). Rotational spectroscopy of the isotopic species of silicon monosulfide, SiS. Physical chemistry chemical physics : PCCP, 9(13), 1579-86. https://doi.org/10.1039/b618799d
Müller, H S P, et al. "Rotational spectroscopy of the isotopic species of silicon monosulfide, SiS." Physical chemistry chemical physics : PCCP vol. 9,13 (2007): 1579-86. doi: https://doi.org/10.1039/b618799d
Müller HS, McCarthy MC, Bizzocchi L, Gupta H, Esser S, Lichau H, Caris M, Lewen F, Hahn J, Degli Esposti C, Schlemmer S, Thaddeus P. Rotational spectroscopy of the isotopic species of silicon monosulfide, SiS. Phys Chem Chem Phys. 2007 Apr 07;9(13):1579-86. doi: 10.1039/b618799d. Epub 2007 Feb 20. PMID: 17429551.
Copy Download .nbib Format: NLM
Application for Medical Scholarships in Italy.

Canadian Medical Association journal

Carosi M.
PMID: 20328166
Can Med Assoc J. 1965 Mar 20;92(12):633.

No abstract available.

Cite
Carosi M. Application for Medical Scholarships in Italy. Can Med Assoc J. 1965;92(12):633
Carosi, M. (1965). Application for Medical Scholarships in Italy. Canadian Medical Association journal, 92(12), 633.
Carosi, M. "Application for Medical Scholarships in Italy." Canadian Medical Association journal vol. 92,12 (1965): 633.
Carosi M. Application for Medical Scholarships in Italy. Can Med Assoc J. 1965 Mar 20;92(12):633. PMID: 20328166; PMCID: PMC1928219.
Copy Download .nbib Format: NLM
Correction to: Roadside monkeys: anthropogenic effects on moor macaque (Macaca maura) ranging behavior in Bantimurung Bulusaraung National Park, Sulawesi, Indonesia.

Primates; journal of primatology

Riley EP, Shafer CA, Trinidad JS, Morrow KS, Sagnotti C, Carosi M, Ngakan PO.
PMID: 34427810
Primates. 2021 Nov;62(6):1045. doi: 10.1007/s10329-021-00941-7.

No abstract available.

Cite
Riley EP, Shafer CA, Trinidad JS, et al. Correction to: Roadside monkeys: anthropogenic effects on moor macaque (Macaca maura) ranging behavior in Bantimurung Bulusaraung National Park, Sulawesi, Indonesia. Primates. 2021;62(6):1045doi: 10.1007/s10329-021-00941-7.
Riley, E. P., Shafer, C. A., Trinidad, J. S., Morrow, K. S., Sagnotti, C., Carosi, M., & Ngakan, P. O. (2021). Correction to: Roadside monkeys: anthropogenic effects on moor macaque (Macaca maura) ranging behavior in Bantimurung Bulusaraung National Park, Sulawesi, Indonesia. Primates; journal of primatology, 62(6), 1045. https://doi.org/10.1007/s10329-021-00941-7
Riley, Erin P, et al. "Correction to: Roadside monkeys: anthropogenic effects on moor macaque (Macaca maura) ranging behavior in Bantimurung Bulusaraung National Park, Sulawesi, Indonesia." Primates; journal of primatology vol. 62,6 (2021): 1045. doi: https://doi.org/10.1007/s10329-021-00941-7
Riley EP, Shafer CA, Trinidad JS, Morrow KS, Sagnotti C, Carosi M, Ngakan PO. Correction to: Roadside monkeys: anthropogenic effects on moor macaque (Macaca maura) ranging behavior in Bantimurung Bulusaraung National Park, Sulawesi, Indonesia. Primates. 2021 Nov;62(6):1045. doi: 10.1007/s10329-021-00941-7. PMID: 34427810.
Copy Download .nbib Format: NLM
[Factors Associated with Prolonged Duration of Labor in Medical Termination of Pregnancy in the 2nd and 3rd Trimesters].

Gynecologie, obstetrique, fertilite & senologie

Doussot M, Barrois M, Anselem O, Tsatsaris V.
PMID: 34768005
Gynecol Obstet Fertil Senol. 2021 Nov 09; doi: 10.1016/j.gofs.2021.11.001. Epub 2021 Nov 09.

OBJECTIVE: In the context of a medical termination of pregnancy, prolonged labor may accentuate the difficulty of women's experience and increase the risk of associated complications. The factors associated with prolonged labor are not known. Reducing the duration of...

Cite
Doussot M, Barrois M, Anselem O, et al. Facteurs associés à une durée de travail prolongée en cas d’interruption médicale de grossesse aux 2 [Factors Associated with Prolonged Duration of Labor in Medical Termination of Pregnancy in the 2nd and 3rd Trimesters]. Gynecol Obstet Fertil Senol. 2021;doi: 10.1016/j.gofs.2021.11.001.
Doussot, M., Barrois, M., Anselem, O., & Tsatsaris, V. (2021). Facteurs associés à une durée de travail prolongée en cas d’interruption médicale de grossesse aux 2 [Factors Associated with Prolonged Duration of Labor in Medical Termination of Pregnancy in the 2nd and 3rd Trimesters]. Gynecologie, obstetrique, fertilite & senologie, . https://doi.org/10.1016/j.gofs.2021.11.001
Doussot, Mathilde, et al. "Facteurs associés à une durée de travail prolongée en cas d’interruption médicale de grossesse aux 2" [Factors Associated with Prolonged Duration of Labor in Medical Termination of Pregnancy in the 2nd and 3rd Trimesters]. Gynecologie, obstetrique, fertilite & senologie vol. (2021). doi: https://doi.org/10.1016/j.gofs.2021.11.001
Doussot M, Barrois M, Anselem O, Tsatsaris V. Facteurs associés à une durée de travail prolongée en cas d’interruption médicale de grossesse aux 2 [Factors Associated with Prolonged Duration of Labor in Medical Termination of Pregnancy in the 2nd and 3rd Trimesters]. Gynecol Obstet Fertil Senol. 2021 Nov 09; doi: 10.1016/j.gofs.2021.11.001. Epub 2021 Nov 09. French. PMID: 34768005.
Copy Download .nbib Format: NLM
[Past and future of life SCIENCE AND RESPONSIBILITY].

Bulletin de l'Academie dentaire

Marois M.
PMID: 5277548
Bull Acad Dent (Paris). 1969 Nov;14:12-21.

No abstract available.

Cite
Marois M. Passé et avenir de la vie SCIENCE ET RESPONSABILITE. [Past and future of life SCIENCE AND RESPONSIBILITY]. Bull Acad Dent (Paris). 1969;14:12-21
Marois, M. (1969). Passé et avenir de la vie SCIENCE ET RESPONSABILITE. [Past and future of life SCIENCE AND RESPONSIBILITY]. Bulletin de l'Academie dentaire, 1412-21.
Marois, M. "Passé et avenir de la vie SCIENCE ET RESPONSABILITE." [Past and future of life SCIENCE AND RESPONSIBILITY]. Bulletin de l'Academie dentaire vol. 14 (1969): 12-21.
Marois M. Passé et avenir de la vie SCIENCE ET RESPONSABILITE. [Past and future of life SCIENCE AND RESPONSIBILITY]. Bull Acad Dent (Paris). 1969 Nov;14:12-21. French. PMID: 5277548.
Copy Download .nbib Format: NLM
Adenodermatofibroma: a rare variant.

Dermatology online journal

Russomanno K, Deng M, Cardis M.
PMID: 34755965
Dermatol Online J. 2021 Aug 15;27(8). doi: 10.5070/D327854711.

Adenodermatofibroma is a newly recognized variant of fibrous histiocytoma (dermatofibroma), a benign lesion frequently encountered in dermatologic practice. There are many established variants of fibrous histiocytoma but there are only eight reported cases of this specific variant in the...

Cite
Russomanno K, Deng M, Cardis M. Adenodermatofibroma: a rare variant. Dermatol Online J. 2021;27(8)doi: 10.5070/D327854711.
Russomanno, K., Deng, M., & Cardis, M. (2021). Adenodermatofibroma: a rare variant. Dermatology online journal, 27(8), . https://doi.org/10.5070/D327854711
Russomanno, Kristen, et al. "Adenodermatofibroma: a rare variant." Dermatology online journal vol. 27,8 (2021). doi: https://doi.org/10.5070/D327854711
Russomanno K, Deng M, Cardis M. Adenodermatofibroma: a rare variant. Dermatol Online J. 2021 Aug 15;27(8). doi: 10.5070/D327854711. PMID: 34755965.
Copy Download .nbib Format: NLM
Terminal 6q deletions cause brain malformations, a phenotype mimicking heterozygous DLL1 pathogenic variants: A multicenter retrospective case series.

Prenatal diagnosis

Lesieur-Sebellin M, Till M, Khau Van Kien P, Herve B, Bourgon N, Dupont C, Tabet AC, Barrois M, Coussement A, Loeuillet L, Mousty E, Ea V, El Assal A, Mary L, Jaillard S, Beneteau C, Le Vaillant C, Coutton C, Devillard F, Goumy C, Delabaere A, Redon S, Laurent Y, Lamouroux A, Massardier J, Turleau C, Sanlaville D, Cantagrel V, Sonigo P, Vialard F, Salomon LJ, Malan V.
PMID: 34894355
Prenat Diagn. 2021 Dec 11; doi: 10.1002/pd.6074. Epub 2021 Dec 11.

OBJECTIVE: Terminal 6q deletion is a rare genetic condition associated with a neurodevelopmental disorder characterized by intellectual disability and structural brain anomalies. Interestingly, a similar phenotype is observed in patients harboring pathogenic variants in the DLL1 gene. Our study...

Cite
Lesieur-Sebellin M, Till M, Khau Van Kien P, et al. Terminal 6q deletions cause brain malformations, a phenotype mimicking heterozygous DLL1 pathogenic variants: A multicenter retrospective case series. Prenat Diagn. 2021;doi: 10.1002/pd.6074.
Lesieur-Sebellin, M., Till, M., Khau Van Kien, P., Herve, B., Bourgon, N., Dupont, C., Tabet, A. C., Barrois, M., Coussement, A., Loeuillet, L., Mousty, E., Ea, V., El Assal, A., Mary, L., Jaillard, S., Beneteau, C., Le Vaillant, C., Coutton, C., Devillard, F., Goumy, C., Delabaere, A., Redon, S., Laurent, Y., Lamouroux, A., Massardier, J., Turleau, C., Sanlaville, D., Cantagrel, V., Sonigo, P., Vialard, F., Salomon, L. J., & Malan, V. (2021). Terminal 6q deletions cause brain malformations, a phenotype mimicking heterozygous DLL1 pathogenic variants: A multicenter retrospective case series. Prenatal diagnosis, . https://doi.org/10.1002/pd.6074
Lesieur-Sebellin, Marion, et al. "Terminal 6q deletions cause brain malformations, a phenotype mimicking heterozygous DLL1 pathogenic variants: A multicenter retrospective case series." Prenatal diagnosis vol. (2021). doi: https://doi.org/10.1002/pd.6074
Lesieur-Sebellin M, Till M, Khau Van Kien P, Herve B, Bourgon N, Dupont C, Tabet AC, Barrois M, Coussement A, Loeuillet L, Mousty E, Ea V, El Assal A, Mary L, Jaillard S, Beneteau C, Le Vaillant C, Coutton C, Devillard F, Goumy C, Delabaere A, Redon S, Laurent Y, Lamouroux A, Massardier J, Turleau C, Sanlaville D, Cantagrel V, Sonigo P, Vialard F, Salomon LJ, Malan V. Terminal 6q deletions cause brain malformations, a phenotype mimicking heterozygous DLL1 pathogenic variants: A multicenter retrospective case series. Prenat Diagn. 2021 Dec 11; doi: 10.1002/pd.6074. Epub 2021 Dec 11. PMID: 34894355.
Copy Download .nbib Format: NLM
Analysis of the hippo transducers TAZ and YAP in cervical cancer and its microenvironment.

Oncoimmunology

Buglioni S, Vici P, Sergi D, Pizzuti L, Di Lauro L, Antoniani B, Sperati F, Terrenato I, Carosi M, Gamucci T, Vincenzoni C, Mariani L, Vizza E, Venuti A, Sanguineti G, Gadducci A, Barba M, Natoli C, Vitale I, Mottolese M, De Maria R, Maugeri-Saccà M.
PMID: 27471633
Oncoimmunology. 2016 Mar 28;5(6):e1160187. doi: 10.1080/2162402X.2016.1160187. eCollection 2016 Jun.

Hippo is a tumor-suppressor pathway that negatively regulates the oncoproteins TAZ and YAP. Moreover, Hippo affects the biology of a variety of non-neoplastic cells in the tumor microenvironment, even including immune cells. We herein assessed the predictive role of...

Cite
Buglioni S, Vici P, Sergi D, et al. Analysis of the hippo transducers TAZ and YAP in cervical cancer and its microenvironment. Oncoimmunology. 2016;5(6):e1160187doi: 10.1080/2162402X.2016.1160187.
Buglioni, S., Vici, P., Sergi, D., Pizzuti, L., Di Lauro, L., Antoniani, B., Sperati, F., Terrenato, I., Carosi, M., Gamucci, T., Vincenzoni, C., Mariani, L., Vizza, E., Venuti, A., Sanguineti, G., Gadducci, A., Barba, M., Natoli, C., Vitale, I., Mottolese, M., De Maria, R., & Maugeri-Saccà, M. (2016). Analysis of the hippo transducers TAZ and YAP in cervical cancer and its microenvironment. Oncoimmunology, 5(6), e1160187. https://doi.org/10.1080/2162402X.2016.1160187
Buglioni, Simonetta, et al. "Analysis of the hippo transducers TAZ and YAP in cervical cancer and its microenvironment." Oncoimmunology vol. 5,6 (2016): e1160187. doi: https://doi.org/10.1080/2162402X.2016.1160187
Buglioni S, Vici P, Sergi D, Pizzuti L, Di Lauro L, Antoniani B, Sperati F, Terrenato I, Carosi M, Gamucci T, Vincenzoni C, Mariani L, Vizza E, Venuti A, Sanguineti G, Gadducci A, Barba M, Natoli C, Vitale I, Mottolese M, De Maria R, Maugeri-Saccà M. Analysis of the hippo transducers TAZ and YAP in cervical cancer and its microenvironment. Oncoimmunology. 2016 Mar 28;5(6):e1160187. doi: 10.1080/2162402X.2016.1160187. eCollection 2016 Jun. PMID: 27471633; PMCID: PMC4938371.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 35 entries